MILLENIUM PHARMA
Timeline
35 events since 1999Board
Capital
Filings
Financial
Establishments
200020052010201520202025
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBabbreviated format · 31 days late
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0467724694
Annual accounts 2024 filed PDFfull format · 20 days late
2024
Annual accounts 2023 filed PDFfull format · 23 days late
2023
Annual accounts 2022 filed PDFfull format · 46 days before the deadline
2022
Annual accounts 2021 filed PDFfull format · 6 days before the deadline
1 director appointed, 1 resignationResignation: Chantal De Saeger · Appointment: AK HERBO PHARMA SRL · Permanent representatives: Ali Kassem and Haouzi Sanae5 points ▸
- Director resignation, Chantal De Saeger
- Director discharge, Chantal De Saeger
- Director appointment, AK HERBO PHARMA SRL
- Permanent representative, Ali Kassem
- Permanent representative, Haouzi Sanae
- The deed holds 1 more point.
2021
1 director appointed, 1 resignationResignation: Chantal De Saeger · Appointment: AK HERBO PHARMA SRL · Permanent representatives: Ali Kassem and Haouzi Sanae5 points ▸
- Director resignation, Chantal De Saeger
- Director discharge, Chantal De Saeger
- Director appointment, AK HERBO PHARMA SRL
- Permanent representative, Ali Kassem
- Permanent representative, Haouzi Sanae
- The deed holds 1 more point.
Annual accounts 2020 filed PDFfull format · 4 days before the deadline
2020
Annual accounts 2019 filed PDFfull format · 31 days late
2019
Highest result from 2006 to 2025 net €261,358 ▲931% The operating result of €288,441 and the net result of €261,358 are both a record.
Annual accounts 2018 filed PDFfull format · 12 days late
2018
Capital decrease of €297,519.30 to €18,592.01Capital from €316,111.31 to €18,592.01 · General meeting of 31-07-20183 points ▸
- General meeting, 31-07-2018
- Capital decrease, €297,519.30
- Amendment of the articles, article 5
- The deed holds 1 more point.
Annual accounts 2017 filed PDFfull format · 6 days before the deadline
2017
Annual accounts 2016 filed PDFfull format · on the deadline day
2016
Equity above €500,000 equity €544,986 ▲10.6% Equity rises from €492,930 to €544,986.
Annual accounts 2015 filed PDFfull format · 2 days late
2015
Annual accounts 2014 filed PDFfull format · 61 days late
2014
Liquidity more than doubled current ratio 1.72 The current ratio rises from 0.70 to 1.72. Short-term debt falls from €603,938 to €237,770.
Annual accounts 2013 filed PDFfull format · 61 days late
2013
Annual accounts 2012 filed PDFfull format · 61 days late
2012
Annual accounts 2011 filed PDFfull format · 57 days late
Annual accounts 2010 filed PDFfull format · 213 days late
2010
Annual accounts 2009 filed PDFfull format · 110 days late
2009
Annual accounts 2008 filed PDFfull format · 92 days late
2008
Annual accounts 2007 filed PDFfull format · 92 days late
2007
Annual accounts 2006 filed PDFfull format · 28 days late
2006
Annual accounts 2005 filed PDFfull format
2005
Annual accounts 2004 filed PDFfull format
2004
Annual accounts 2003 filed PDFfull format
2003
Annual accounts 2002 filed PDFfull format
2002
Annual accounts 2001 filed PDFfull format
2001
Annual accounts 2000 filed PDFfull format
2000
First establishment Van Overbekelaan 153, Ganshoren
1999
Incorporation published on 09-12-1999
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank